FIELD: chemistry.
SUBSTANCE: group of inventions discloses a method of producing carbamylated darbepoetin 9C-DEPO, which is carbamylated on all amino acid residues of lysine which are part of a darbepoetin molecule, containing a carbamylated amino acid residue of alanine in the N-terminal region of said protein, which includes carbamylation of darbepoetin in the presence of cyanates, as well as a medicinal agent which includes carbamylated darbepoetin 9C-DEPO.
EFFECT: group of inventions has marked cytoprotective action.
2 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXPRESSION VECTOR, EUKARYOTIC PRODUCER STRAIN AND METHOD OF PRODUCING DARBEPOETIN ALPHA | 2022 |
|
RU2819866C2 |
| CHINESE HAMSTER OVARY CELL LINE STRAIN | 2023 |
|
RU2805879C1 |
| EUKARYOTIC HOST CELL FOR EXPRESSION OF DARBEPOETIN, EXPRESSION VECTOR AND METHOD OF PRODUCTION OF DARBEPOETIN ALFA | 2013 |
|
RU2523948C1 |
| METHOD OF CORRECTION OF MICROCIRCULATION DISORDERS IN PLACENTA WITH CARBAMYLATED DARBEPOETIN IN ADMA-LIKE MODEL OF PREECLAMPSIA | 2019 |
|
RU2720103C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION WITH CARBAMYLATED DARBEPOETIN IN ADMA-LIKE MODEL OF PREECLAMPSIA | 2019 |
|
RU2707057C1 |
| METHOD FOR PREVENTING RENAL ISCHEMIA REPERFUSION INJURY BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2678768C1 |
| METHOD FOR PREVENTING RENAL DYSFUNCTIONS WITH CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2695334C1 |
| STRAIN OF CHINESE HAMSTER OVARY CELLS CHO-EPO 4A9 - PRODUCER OF HIGHLY SIALYLATED ERYTHROPOETHIN | 2016 |
|
RU2652884C1 |
| METHOD FOR PREVENTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2017 |
|
RU2643579C1 |
| EXTENDED FACTOR OF HUMAN ERYTHROPOIESIS AND A THERAPEUTIC AGENT BASED THEREON | 2015 |
|
RU2664588C2 |
